Clinical Trial Update: A Study to Evaluate the Safety, Tolerability, and PK in Healthy Volunteers and HCV Genotype 1 Infected Patients [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating safety, tolerability, and pharmacokinetics in healthy volunteers and Hepatitis C genotype 1–infected patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Snippet

Sponsor: TaiGen Biotechnology Co., Ltd. | Conditions: Healthy, Hepatitis C, Chronic | Phase 1 | Status: COMPLETED